(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(-0.22%) $82.63
(0.60%) $1.663
(-0.32%) $2 330.90
(-0.20%) $27.29
(-0.29%) $913.10
(0.03%) $0.935
(0.16%) $11.00
(0.06%) $0.803
(0.02%) $92.34
Live Chart Being Loaded With Signals
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases...
Stats | |
---|---|
Today's Volume | 755 858 |
Average Volume | 99 535.00 |
Market Cap | 5.16M |
EPS | $0 ( 2024-02-26 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0286 |
ATR14 | $0.00200 (3.51%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-02-24 | Appelhans Dannielle | Sell | 10 385 | Common Stock |
2023-02-01 | Cagnoni Pablo J | Sell | 8 448 | Common Stock |
2023-01-31 | Appelhans Dannielle | Sell | 7 500 | Restricted Stock Units |
2023-01-31 | Appelhans Dannielle | Buy | 7 500 | Common Stock |
2023-02-01 | Appelhans Dannielle | Sell | 3 878 | Common Stock |
INSIDER POWER |
---|
26.91 |
Last 96 transactions |
Buy: 4 525 378 | Sell: 349 777 |
Volume Correlation
Rubius Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
ALVR | 0.895 |
ARQT | 0.889 |
ENNV | 0.881 |
AKYA | 0.87 |
CTKB | 0.868 |
CMCT | 0.866 |
PAIC | 0.864 |
AMTX | 0.861 |
AMTB | 0.858 |
CATY | 0.857 |
10 Most Negative Correlations | |
---|---|
BOCH | -0.881 |
SMCI | -0.877 |
NETE | -0.867 |
LONE | -0.862 |
TRMD | -0.86 |
RAVN | -0.854 |
SHSP | -0.848 |
NEO | -0.823 |
MMAC | -0.823 |
BNIXU | -0.813 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rubius Therapeutics Inc Correlation - Currency/Commodity
Rubius Therapeutics Inc Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.56 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.460 |
Q3 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.030 |
Q2 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.500 |
Financial Reports:
No articles found.
Rubius Therapeutics Inc
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators